Company profile: Prothya Biosolutions
1.1 - Company Overview
Company description
- Provider of plasma protein therapeutics and services, including immunoglobulin for primary/secondary immunodeficiency and neuromuscular disorders (MMN, CIDP); albumin for blood loss, burns, and sepsis; prothrombin complex and Cofact for coagulation disorders. Offers product/process development (viral safety, formulations, stability, characterization) and contract manufacturing of plasma intermediates, APIs, drug substances, and final products.
Products and services
- Albumin: Plasma-derived protein administered to restore blood flow in patients suffering significant blood loss and used in the treatment of severe burns or sepsis
- Immunoglobulin: Clinical-grade plasma protein containing a broad spectrum of antibodies, administered intravenously for treating primary and secondary immunodeficiency diseases and neuromuscular disorders such as MMN and CIDP
- Prothrombin complex: Multi-factor concentrate containing coagulation factors used in anticoagulation therapy for emergency correction of coagulation, such as acute hemorrhaging or emergency surgery, and for patients with congenital coagulation deficiency
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Prothya Biosolutions
Red Nucleus
HQ: United States
Website
- Description: Provider of award-winning e-learning, digital content, and performance solutions for the Life Sciences industry, specializing in professional training, marketing learning systems, and workshops that engage client-facing teams throughout their continuing education journey, with offices in the US, UK, and India.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Red Nucleus company profile →
Gallus BioPharma
HQ: United States
Website
- Description: Provider of contract manufacturing and development services for mammalian cell culture-derived biologics, supplying clinical and commercial bulk biologics to the biopharmaceutical industry in the United States and internationally, with capabilities in process and analytical development, process validation, cell banking, stability testing, QA/QC, regulatory support, and aseptic fill-finish (vial filling, inspection, labeling).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gallus BioPharma company profile →
Diaceutics
HQ: United Kingdom
Website
- Description: Provider of analytics, software, services and consulting that help pharmaceutical companies integrate diagnostic testing into treatment pathways, offering DXRX – The Diagnostic Network for collaboration and global real-world testing data, DXRX Data Solutions, DXRX Marketplace, DXRX Signal for testing behavior alerts, and insights via DXRX Physician Mapping and DXRX Lab Mapping.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diaceutics company profile →
Agility Clinical
HQ: United States
Website
- Description: Provider of consulting and contract research services for virtual and small biopharma and device companies with lean infrastructure, offering expertise to support programs—particularly in orphan drug development—and help them move forward.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Agility Clinical company profile →
AGC Biologics
HQ: Denmark
Website
- Description: Provider of biopharmaceutical contract development and manufacturing services, including microbial fermentation and mammalian cell culture cGMP manufacturing, process development and scale-up, and production of biopharmaceuticals for pre-clinical, clinical, and market supply. Offers CDMO services for biologics and ATMPs, AGCellerate (DNA-to-IND), lentiviral and AAV vector production, and ADC development and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AGC Biologics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Prothya Biosolutions
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Prothya Biosolutions
2.2 - Growth funds investing in similar companies to Prothya Biosolutions
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Prothya Biosolutions
4.2 - Public trading comparable groups for Prothya Biosolutions
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →